Loading…
Reported covered position: Congressman Rogers Staff; Congressman Shimkus, Staff
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Middle Class Tax (AMT) Relief Act of 2007
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · first_quarter · 1A
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2010 · second_quarter · Q2
Source: Senate LDA
| BIOTECHNOLOGY INDUSTRY ORGANIZATION |
| 12 |
| 2008–2010 |
| MEDIMMUNE INC | 12 | 2008–2010 |
| NANOINK INC | 12 | 2008–2010 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 12 | 2008–2010 |
| PHARMATHENE, INC. | 12 | 2008–2010 |
| ABBOTT LABORATORIES | 11 | 2008–2010 |
| ASTRAZENECA PHARMACEUTICALS LP | 11 | 2008–2010 |
| GENENTECH INC | 9 | 2008–2009 |
| MICROSOFT CORPORATION | 9 | 2009–2010 |
| PARTNERSHIP TO IMPROVE PATIENT CARE | 9 | 2008–2010 |
| TETHYS BIOSCIENCE | 8 | 2008–2009 |
| ACADEMY OF MOLECULAR IMAGING | 6 | 2008–2009 |
| AMGEN | 5 | 2008 |
| CUBIST PHARMACEUTICALS | 5 | 2008 |
| LONG TERM CARE PHARMACY ALLIANCE | 3 | 2008–2009 |
American Middle Class Tax (AMT) Relief Act of 2007
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: NANOINK INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MICROSOFT CORPORATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PARTNERSHIP TO IMPROVE PATIENT CARE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MICROSOFT CORPORATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MCNEIL CONSUMER HEALTHCARE LLC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ADAMAS PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Health Care and Education Affordability Reconciliation Act (H.R. 4872); Implementation of pandemic, biodefense preparedness and Appropriations Legislation
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: NANOINK INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SUSAN G KOMEN FOR THE CURE · Firm: FOLEY HOAG LLP
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ADAMAS PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Health Care and Education Affordability Reconciliation Act (H.R. 4872) Implementation of pandemic, biodefense preparedness and Appropriations Legislation
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PHARMATHENE INC · Firm: FOLEY HOAG LLP
Health Care and Education Affordability Reconciliation Act (H.R. 4872); Implementation of biodefense preparedness relate legislation and Department of Health and Human Services Appropriations
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R.1427, H.R.1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on biologics legislation - H.R.1427, H.R.1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act America's Affordable Health Choices Act H.R.3200 Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 Comparative Effectiveness Research, American Recovery and Reinvestment Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act, HR 759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Follow-on Biologics -HR1427, HR 1548 FDA Globalization Act - HR 759
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, S.1695
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Follow-on biologics legislation - HR 1427, HR 1548 Physician Payments Sunshine Act - S. 301 FDA Globalization Act - HR 759
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act - H.R. 3590; Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 ARRA; Comparative effectiveness research
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act- H.R. 3200
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Food and Drug legislation Safe-guarding America's Pharmaceutical Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: GENENTECH INC · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Choices Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics- H.R.1427, H.R.1548 Physician Payments Sunshine Act- S.301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ABBOTT LABORATORIES · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Pathway for Biosimilars Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Pathway for Biosimilars Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Pathway for Biosimilars Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
S.__ Affordable Healthy Futures Act America's Affordable Health Choices Act H.R.3200 Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Follow-on Biologics -HR1427, HR 1548 FDA Globalization Act - HR 759
Pathway for Biosimilars Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
FDA Globalization Act, HR 759 Follow-on biologics -HR 1427, HR 1548 Physician Payments Sunshine Act - S 301
Follow-on Biologics- HR 1427, HR 1548 Food and Drug legislation Safe-guarding America's Pharmaceutical Act
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Pathway for Biosimilars Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on biologics legislation - H.R.1427, H.R.1548
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) Implementation of biodefense preparedness relate legislation and Department of Health and Human Services Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid issues associated with the Patient Protection and Affordable Care Act of 2010, H.R. 3590 American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES
NANOINK INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Regulation of OTC drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAMAS PHARMACEUTICALS via FOLEY HOAG LLP
2010 · second_quarter · Q2
Health Care and Education Affordability Reconciliation Act (H.R. 4872) Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMATHENE INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Health Care and Education Affordability Reconciliation Act (H.R. 4872); Implementation of biodefense preparedness relate legislation and Department of Health and Human Services Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES
NANOINK INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAMAS PHARMACEUTICALS via FOLEY HOAG LLP
2010 · first_quarter · Q1
Health Care and Education Affordability Reconciliation Act (H.R. 4872); Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2009 · first_quarter · 1@
Medicare Payment for Diabetes screening; Healthcare Reform and Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2@
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2@
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2@
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · 2@
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Anti-counterfeiting technology regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2009 · second_quarter · 2@
Affordable Health Choices Act; Implementation of health information technology provisions of H.R.1 American Recovery and Reinvestment Act
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2@
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3@
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2@
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TETHYS BIOSCIENCE via FOLEY HOAG LLP
2009 · first_quarter · 1A
Medicare Payment for Diabetes screening; Healthcare Reform and Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MOLECULAR IMAGING via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicare coverage of PET scans for cancer indicators
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2A
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2A
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2A
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Anti-counterfeiting technology regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2009 · second_quarter · 2A
Affordable Health Choices Act; Implementation of health information technology provisions of H.R.1 American Recovery and Reinvestment Act
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · second_quarter · 2A
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R. 3590; Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Implementation of biodefense preparedness related legislation and Department of Health and Human Services Appropriations Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Safe-guarding America's Pharmaceuticals Act ; FDA Globalization Act - H.R.759; Medicare Improvement for Patients and Providers Act; FDA Amendments Act Implementation and Rulemaking Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Implementation of health information technology provisions of H.R.1 American Recovery and Reinvestment Act
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Non-Prescription Drug Modernization Act - H.R.4083, S.2317 FDA Globalization Act - H.R.759 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAMAS PHARMACEUTICALS via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on biologics legislation - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Non-Prescription Drug Modernization Act - H.R.4083, S.2317 FDA Globalization Act - H.R.759
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · third_quarter · Q3
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act- H.R. 3200
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act America's Affordable Health Choices Act H.R.3200 Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATHENE INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Implementation of biodefense preparedness related legislation and Department of Health and Human Services Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Anti-counterfeiting technology regulations FDA Risk Evaluation Mitigation Strategy Implementation and Rulemaking
Safe-guarding America's Pharmaceuticals Act FDA Globalization Act - H.R.759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Americas Healthy Futures Act Implementation of health information technology provisions of H.R.1 American Recovery and Reinvestment Act
ADAMAS PHARMACEUTICALS via FOLEY HOAG LLP
2009 · third_quarter · Q3
Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G KOMEN FOR THE CURE via FOLEY HOAG LLP
2009 · third_quarter · Q3
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · third_quarter · Q3
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Choices Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics- H.R.1427, H.R.1548 Physician Payments Sunshine Act- S.301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2009 · second_quarter · Q2
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · Q2
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via FOLEY HOAG LLP
2009 · second_quarter · Q2
Affordable Health Choices Act; Implementation of health information technology provisions of H.R.1 American Recovery and Reinvestment Act
PHARMATHENE INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Implementation of biodefense related legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Non-Prescription Drug Modernization Act - H.R. 4083, S. 2317 FDA Globalization Act - H.R. 759
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · Q2
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NANOINK INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Anti-counterfeiting technology regulations
Safe-guarding America's Pharmaceuticals FDA Globalization Act - HR 759 Medicare Improvement for Patients and Providers Act FDA Amendments Act Implementation and Rulemaking
Filing targets: HOUSE OF REPRESENTATIVES, SENATE